Evidence map›Paper›PMID 20501441›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2009

Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis.

Ludmila Khailova, Katerina Dvorak, Kelly M Arganbright, Melissa D Halpern, Toshi Kinouchi, Masako Yajima, Bohuslav Dvorak

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 111 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
111citing papers in PubMed, 2 pooled it
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

111 citing papers in PubMed, 2 syntheses or guidelines pooled it, 200 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Bifidobacterium and enteral feeding in preterm infants: cluster-randomized trial.Pediatrics international : official journal of the Japan Pediatric Society · 2014
    Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Characterization of Peptide Utilization byFood science & nutrition · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Probiotics and the intestinal tight junction barrier function.Frontiers in cell and developmental biology · 2025
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

51 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Ludmila KhailovaDepartment of Pediatrics, University of Arizona, Tucson, Arizona 85724-5073, USA.
Katerina Dvorak
Kelly M Arganbright
Melissa D Halpern
Toshi Kinouchi
Masako Yajima
Bohuslav Dvorak
University of Arizona · USHokkaido University · JPMeiji University · JP

Funding

Mechanism of EGF-Mediated Reduction of NECR01HD039657 · NICHD · UNIVERSITY OF ARIZONA · PI DVORAK, BOHUSLAV · 2001 to 2009
$2.6M
NICHD NIH HHS HD039657
6 · The paper itself

Abstract

Neonatal necrotizing enterocolitis (NEC) is a major cause of morbidity and mortality in premature infants. Oral administration of probiotics has been suggested as a promising strategy for prevention of NEC. However, little is known about the mechanism(s) of probiotic-mediated protection against NEC. The aim of this study was to evaluate the effects of Bifidobacterium bifidum treatment on development of NEC, cytokine regulation, and intestinal integrity in a rat model of NEC. Premature rats were divided into three groups: dam fed (DF), hand fed with formula (NEC), or hand fed with formula supplemented with 5 x 10(6) CFU B. bifidum per day (B. bifidum). All groups were exposed to asphyxia and cold stress to develop NEC. Intestinal injury, mucin and trefoil factor 3 (Tff3) production, cytokine levels, and composition of tight junction (TJ) and adherens junction (AJ) proteins were evaluated in the terminal ileum. B. bifidum decreased the incidence of NEC from 57 to 17%. Increased levels of IL-6, mucin-3, and Tff3 in the ileum of NEC rats was normalized in B. bifidum treated rats. Reduced mucin-2 production in the NEC rats was not affected by B. bifidum. Administration of B. bifidum normalized the expression and localization of TJ and AJ proteins in the ileum compared with animals with NEC. In conclusion, administration of B. bifidum protects against NEC in the neonatal rat model. This protective effect is associated with reduction of inflammatory reaction in the ileum, regulation of main components of mucus layer, and improvement of intestinal integrity.

Indexed as

BifidobacteriumAdherens JunctionsAnimalsAnimals, NewbornAsphyxiaCadherinsCateninsClaudin-3Cold TemperatureDisease Models, AnimalEnterocolitis, NecrotizingEnterocytesGene ExpressionIleumIncidenceInterleukinsCadherinsCateninsClaudin-3Cldn3 protein, ratInterleukinsMembrane ProteinsMuc2 protein, ratMuc3 protein, ratMucin-2Mucin-3NeuropeptidesOccludinOcln protein, ratTFF3 protein, ratTrefoil Factor-3Tumor Necrosis Factor-alpha

Identifiers

PMID20501441
PMCPMC2777452
OpenAlexW2063376552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.